Midazolam 0 — Class I drug recall D-1362-2014
Terminated recall by Pharmakon Pharmaceuticals, reported 2014-06-18, distributed in IN. Superpotent Drug: Product contains twice the stated amount of midazolam.
| Recall number | D-1362-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pharmakon Pharmaceuticals, Noblesville, IN, United States |
| Recall initiated | 2014-03-26 |
| Classified | 2014-06-09 |
| Reported by FDA | 2014-06-18 |
| Terminated | 2014-07-31 |
| Distributed | IN |
| Quantity | 80 syringes |
| Reason classes | potency |
| NDC | 45183-0014-69 |
| Lot numbers | E0433735C, E1016227C |
| Expiration dates | 2014-04-20, 2014-04-21 |
Product
Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.
Reason for recall
Superpotent Drug: Product contains twice the stated amount of midazolam.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1362-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.